QA: Context Therapeutics Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001842952_2022_Context_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Ignoring company because Expenses is zero pre-agg {'balance_sheet': {'company_id': '0001842952', 'EntityCommonStockSharesOutstanding': 15966053, 'Assets': 37965943, 'AssetsCurrent': 37853658, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 3207577, 'LiabilitiesAndStockholdersEquity': 37965943, 'LiabilitiesCurrent': 3207577, 'LiabilitiesNoncurrent': 0, 'NetIncome': -14835939, 'PropertyPlantAndEquipmentNet': 27568, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 84717, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 34758366, 'remainder_NetIncome': -14835939, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}}

Graph

Absolute values for 0001842952, Context Therapeutics Inc

  xvar xval
0 AssetsCurrent 51,255,361
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 50,389
4 LiabilitiesCurrent 3,033,415
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 64,240
11 remainder_Revenues 0
12 remainder_NetIncome -10,392,630
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 51,305,750
1 Liabilities 3,033,415
2 Expenses 64,240
3 Revenues 0
4 StockholdersEquity 48,272,335
5 NetIncome -10,456,870
6 ComprehensiveNetIncome -10,456,870
7 BaseVar 32,398,018
8 EconomicCapitalRatiobeforeLimitedLiability 3.49
9 EconomicCapitalRatio 4.02

Edgar->Model Mapping

Feature Distribution